Oxidized Haemoglobin–Driven Endothelial Dysfunction and Immune Cell Activation: Novel Therapeutic Targets for Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|37|4806-4814

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.37, 2013-11, pp. : 4806-4814

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets

By  

Current Medicinal Chemistry, Vol. 16, Iss. 1, 2009-01 ,pp. : 94-112

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial dysfunction in atherosclerosis

By Callow A.D.  

General Pharmacology, Vol. 38, Iss. 5, 2002-05 ,pp. : 257-258

Elsevier

Access to resources Recommend Favorite

Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine

By  

Current Pharmaceutical Design, Vol. 22, Iss. 30, 2016-09 ,pp. : 4658-4668

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic targets in mantle cell lymphoma

By Martin Peter   Leonard John P  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 929-940

Informa Healthcare

Access to resources Recommend Favorite

Oxidative Stress, Endothelial Dysfunction and Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 15, Iss. 26, 2009-09 ,pp. : 2988-3002

Bentham Science Publishers

Access to resources Recommend Favorite